These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 21170112

  • 1. [Small hepatocellular carcinoma in patients with hepatitis B-induced cirrhosis: a comparison between MRI and MDCT].
    Jiang YY, Wang XY, Guo XM, Jiang XX.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec 18; 42(6):767-72. PubMed ID: 21170112
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
    Kim YK, Kwak HS, Kim CS, Chung GH, Han YM, Lee JM.
    Radiology; 2006 Feb 18; 238(2):531-41. PubMed ID: 16371577
    [Abstract] [Full Text] [Related]

  • 3. Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning.
    Zhao H, Yao JL, Wang Y, Zhou KR.
    World J Gastroenterol; 2007 Feb 28; 13(8):1252-6. PubMed ID: 17451209
    [Abstract] [Full Text] [Related]

  • 4. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
    Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK.
    AJR Am J Roentgenol; 2009 Jun 28; 192(6):1675-81. PubMed ID: 19457834
    [Abstract] [Full Text] [Related]

  • 5. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, Katahira K, Takahashi M.
    AJR Am J Roentgenol; 1999 Jun 28; 172(6):1547-54. PubMed ID: 10350287
    [Abstract] [Full Text] [Related]

  • 6. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y.
    J Magn Reson Imaging; 2009 Feb 28; 29(2):341-9. PubMed ID: 19161186
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK, Kwak HS, Han YM, Kim CS.
    J Comput Assist Tomogr; 2007 Feb 28; 31(5):702-11. PubMed ID: 17895780
    [Abstract] [Full Text] [Related]

  • 8. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
    Kanematsu M, Hoshi H, Murakami T, Inaba Y, Kim T, Yamada T, Kato M, Yokoyama R, Nakamura H.
    AJR Am J Roentgenol; 1997 Dec 28; 169(6):1507-15. PubMed ID: 9393154
    [Abstract] [Full Text] [Related]

  • 9. Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography.
    Kakihara D, Nishie A, Harada N, Shirabe K, Tajima T, Asayama Y, Ishigami K, Nakayama T, Takayama Y, Okamoto D, Fujita N, Kishimoto J, Honda H.
    J Magn Reson Imaging; 2014 Nov 28; 40(5):1112-20. PubMed ID: 24259437
    [Abstract] [Full Text] [Related]

  • 10. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M, Ito K, Shimizu A, Fujita T, Onoda H, Yamatogi S, Washida Y, Matsunaga N.
    Magn Reson Imaging; 2009 Jul 28; 27(6):801-6. PubMed ID: 19144487
    [Abstract] [Full Text] [Related]

  • 11. MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis.
    Bartolozzi C, Donati F, Cioni D, Crocetti L, Lencioni R.
    Eur Radiol; 2000 Jul 28; 10(11):1697-702. PubMed ID: 11097390
    [Abstract] [Full Text] [Related]

  • 12. Ferucarbotran-enhanced 3.0-T magnetic resonance imaging using parallel imaging technique compared with triple-phase multidetector row computed tomography for the preoperative detection of hepatocellular carcinoma.
    Kim SJ, Kim SH, Lee J, Chang S, Kim YS, Kim SH, Jeon YH, Choi D.
    J Comput Assist Tomogr; 2008 Jul 28; 32(3):379-85. PubMed ID: 18520541
    [Abstract] [Full Text] [Related]

  • 13. Detectability of hepatocellular carcinoma on gadoxetic acid-enhanced MRI at 3 T in patients with severe liver dysfunction: clinical impact of dual-source parallel radiofrequency excitation.
    Nishie A, Kakihara D, Asayama Y, Ushijima Y, Takayama Y, Fujita N, Shimamoto D, Shirabe K, Hida T, Honda H.
    Clin Radiol; 2015 Mar 28; 70(3):254-61. PubMed ID: 25522901
    [Abstract] [Full Text] [Related]

  • 14. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.
    Lee JM, Kim IH, Kwak HS, Youk JH, Han YM, Kim CS.
    Korean J Radiol; 2003 Mar 28; 4(1):1-8. PubMed ID: 12679628
    [Abstract] [Full Text] [Related]

  • 15. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis.
    Hanna RF, Kased N, Kwan SW, Gamst AC, Santosa AC, Hassanein T, Sirlin CB.
    AJR Am J Roentgenol; 2008 Jan 28; 190(1):47-57. PubMed ID: 18094293
    [Abstract] [Full Text] [Related]

  • 16. Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma.
    Kim YK, Kim CS, Chung GH, Han YM, Lee SY, Chon SB, Lee JM.
    AJR Am J Roentgenol; 2006 Jan 28; 186(1):149-57. PubMed ID: 16357395
    [Abstract] [Full Text] [Related]

  • 17. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep 28; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]

  • 18. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ, Kim YK, Lee MH, Lee JH.
    Acta Radiol; 2013 Mar 01; 54(2):127-36. PubMed ID: 23148300
    [Abstract] [Full Text] [Related]

  • 19. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
    Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, Lim HK, Lee SJ.
    AJR Am J Roentgenol; 2005 Apr 01; 184(4):1069-76. PubMed ID: 15788575
    [Abstract] [Full Text] [Related]

  • 20. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (<or=3 cm) detection].
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y, Chen CZ, Shen JZ, Li RC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 10; 89(9):592-6. PubMed ID: 19595157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.